In particular, CTLA4-Ig 100 μg/mL significantly upregulated the gene expression of CD163 and CD206 after 3 h of treatment compared to unstimulated RA-MDMs (p < 0.05; Fig. 3B). The gene discussed is CTLA4; the disease is rheumatoid arthritis.